Regional Collaboration and Trends in Clinical Management of Thyroid Cancer.

clinical management oncological network thyroid cancer

Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
18 Aug 2023
Historique:
revised: 05 07 2023
received: 13 05 2023
accepted: 19 07 2023
medline: 18 8 2023
pubmed: 18 8 2023
entrez: 18 8 2023
Statut: aheadofprint

Résumé

This study examines the trends in the management of thyroid cancer and clinical outcomes in the Southwestern region of The Netherlands from 2010 to 2021, where a regional collaborative network has been implemented in January 2016. Retrospective cohort study. This study encompasses all patients diagnosed with thyroid cancer of any subtype between January 2010 and June 2021 in 10 collaborating hospitals in the Southwestern region of The Netherlands. The primary outcome of this study was the occurrence of postoperative complications. Secondary outcomes were trends in surgical management, centralization, and waiting times of patients with thyroid cancer. This study included 1186 patients with thyroid cancer. Median follow-up was 58 [interquartile range: 24-95] months. Surgery was performed in 1027 (86.6%) patients. No differences in postoperative complications, such as long-term hypoparathyroidism, permanent recurrent nerve paresis, or reoperation due to bleeding were seen over time. The percentage of patients with low-risk papillary thyroid carcinoma referred to the academic hospital decreased from 85% (n = 120/142) in 2010 to 2013 to 70% (n = 120/171) in 2014 to 2017 and 62% (n = 100/162) in 2018 to 2021 (P < .01). The percentage of patients undergoing a hemithyroidectomy alone was 9% (n = 28/323) in 2010 to 2013 and increased to 20% (n = 63/317; P < .01) in 2018 to 2021. The establishment of a regional oncological network coincided with a de-escalation of thyroid cancer treatment and centralization of complex patients and interventions. However, no differences in postoperative complications over time were observed. Determining the impact of regional oncological networks on quality of care is challenging in the absence of uniform quality indicators.

Identifiants

pubmed: 37595096
doi: 10.1002/ohn.481
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 The Authors. Otolaryngology-Head and Neck Surgery published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Références

Oates J, Bjerregaard Jensen H. Building Regional Health Care Networks in Europe. IOS Press; 2000:238.
Anderson BO, Yip C-H, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer. 2008;113(S8):2221-2243.
D'cruz A, Lin T, Anand AK, et al. Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines. Oral Oncol. 2013;49(9):872-877.
Carpenter WR, Meyer A-M, Wu Y, et al. Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation. Med Care. 2012;50(8):737-748.
Penn DC, Chang Y, Meyer A-M, et al. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community. Cancer. 2015;121(1):93-101.
Penn DC, Stitzenberg KB, Cobran EK, Godley PA. Provider-based research networks demonstrate greater hospice use for minority patients with lung cancer. J Oncol Pract. 2014;10(4):e182-e190.
Fouad MN, Lee JY, Catalano PJ, et al. Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract. 2013;9(2):e40-e47.
McAlearney AS, Song PH, Reiter KL. Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program. Contemp Clin Trials. 2012;33(6):1143-1149.
van Dijk SPJ, Lončar I, van Veen-Berkx E, et al. Establishing a multicenter network for patients with thyroid nodules and cancer: effects on referral patterns. Otolaryngol Head Neck Surg. 2023;168:91-100.
Mascia D, Angeli F, Di Vincenzo F. Effect of hospital referral networks on patient readmissions. Soc Sci Med. 2015;132:113-121.
Spear SE. Reducing readmissions to detoxification: an interorganizational network perspective. Drug Alcohol Depend. 2014;137:76-82.
Uddin S, Hossain L, Kelaher M. Effect of physician collaboration network on hospitalization cost and readmission rate. Eur J Public Health. 2011;22(5):629-633.
De Juiste Zorg op de Juiste Plek. Taskforce report: the right care in the right place. 2018. Accessed May 13, 2023. https://www.dejuistezorgopdejuisteplek.nl/.uc/fcef77d2b01028d5c0000bd7ca7026baaac90942d76c900/The%20right%20care%20in%20the%20right%20place_report%20taskforce.pdf
Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808.
Siciliani L, Moran V, Borowitz M. What works? Waiting time policies in the health sector. Eurohealth. 2015;21(4):14-17.
Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol. 2022;186(2):R33-R63.
Edge SB, Byrd DR, Carducci MA, Compton CC, Fritz AG, Greene FL. AJCC Cancer Staging Manual. Springer; 2010.
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133.
Links T. Richtlijn voor de diagnostiek, behandeling en follow-up van patiënten met gedifferentieerd (niet-medullair) schildkliercarcinoom [pdf]. 2015. Accessed May 13, 2023. https://www.nhg.org/sites/default/files/content/nhg_org/uploads/schildkliercarcinoom.pdf
Gordon AJ, Dublin JC, Patel E, et al. American Thyroid Association guidelines and national trends in management of papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg. 2022;148:1156-1163.
Graham RMM, Miller Wolman D, Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, et al. Promoting Adoption of Clinical Practice Guidelines. National Academies Press; 2011.
Metman MJH, Lončar I, Kruijff S, Engelsman AF, van Ginhoven TM. Is less always more in a national well-differentiated thyroid cancer population? Eur J Surg Oncol. 2020;46(4):709-711.
Ministerie van Volksgezondheid, Welzijn en Sport (VWS) en de NederlandseZorgautoriteit (NZa). Bestuurlijk Akkoord Plan van aanpak ROBIJN. VWS, NZa; 2017.
Birkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128-1137.
Papaleontiou M, Hughes DT, Guo C, Banerjee M, Haymart MR. Population-based assessment of complications following surgery for thyroid cancer. J Clin Endocrinol Metab. 2017;102(7):2543-2551.
de Bock E, Herman ES, Bastian OW, Filipe MD, Vriens MR, Richir MC. Systematic review and meta-analysis determining the effect of implemented COVID-19 guidelines on surgical oncology volumes and clinical outcomes. Surg Oncol. 2022;45:101859.
Basta YL, Bolle S, Fockens P, Tytgat KMAJ. The value of multidisciplinary team meetings for patients with gastrointestinal malignancies: a systematic review. Ann Surg Oncol. 2017;24(9):2669-2678.
Ung KA, Campbell BA, Duplan D, Ball D, David S. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer. Asia-Pac J Clin Oncol. 2016;12(2):e298-e304.
Specchia ML, Frisicale EM, Carini E, et al. The impact of tumor board on cancer care: evidence from an umbrella review. BMC Health Serv Res. 2020;20(1):73.
Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56-72.
Basse C, Thureau S, Bota S, et al. Multidisciplinary tumor board decision making for postoperative radiotherapy in thymic epithelial tumors: insights from the RYTHMIC prospective cohort. J Thorac Oncol. 2017;12(11):1715-1722.
Berardi R, Morgese F, Rinaldi S, et al. Benefits and limitations of a multidisciplinary approach in cancer patient management. Cancer Manag Res. 2020;12:9363-9374.
Shin DW, Cho J, Kim SY, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20(8):2468-2476.
Chaves N, Broekhuis JM, Fligor SC, et al. Delay in surgery and papillary thyroid cancer survival in the United States: a SEER-medicare analysis. J Clin Endocrinol Metab. 2023;dgad163.
Lončar I, Noltes ME, Dickhoff C, et al. Persistent postthyroidectomy hypoparathyroidism in the Netherlands. JAMA Otolaryngol Head Neck Surg. 2021;147(11):959-965.
Díez JJ, Anda E, Sastre J, et al. Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis. Endocrine. 2019;66(2):405-415.
Annebäck M, Hedberg J, Almquist M, Stålberg P, Norlén O. Risk of permanent hypoparathyroidism after total thyroidectomy for benign disease: a nationwide population-based cohort study from Sweden. Ann Surg. 2021;274(6):e1202-e1208.
Christou N, Mathonnet M. Complications after total thyroidectomy. J Visceral Surg. 2013;150(4):249-256.
Ako-Arrey DE, Brouwers MC, Lavis JN, Giacomini MK, Team A-H. Health systems guidance appraisal-a critical interpretive synthesis. Implement Sci. 2016;11:9.
Mak KS, van Bommel ACM, Stowell C, et al. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J. 2016;48(3):852-860.
Martin NE, Massey L, Stowell C, et al. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. 2015;67(3):460-467.
Ong WL, Schouwenburg MG, van Bommel ACM, et al. A standard set of value-based patient-centered outcomes for breast cancer: the International Consortium for Health Outcomes Measurement (ICHOM) Initiative. JAMA Oncol. 2017;3(5):677-685.
Liu RQ, Wiseman SM. Quality indicators for thyroid cancer surgery: current perspective. Expert Rev Anticancer Ther. 2016;16(9):919-928.
Cadilhac DA, Lannin NA, Anderson CS, et al. Protocol and pilot data for establishing the Australian Stroke Clinical Registry. Int J Stroke. 2010;5(3):217-226.
Centers for Disease Control and Prevention (CDC). Use of a registry to improve acute stroke care-seven states, 2005-2009. MMWR Morb Mortal Wkly Rep. 2011;60(7):206-210.
Kolias AG, Bulters DO, Cowie CJ, et al. Proposal for establishment of the UK Cranial Reconstruction Registry (UKCRR). Br J Neurosurg. 2014;28(3):310-314.

Auteurs

Sam P J van Dijk (SPJ)

Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Hannelore I Coerts (HI)

Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Ivona Lončar (I)

Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Caroline M J van Kinschot (CMJ)

Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.
Department of Internal Medicine, Maasstad Hospital Rotterdam, Rotterdam, The Netherlands.

Erik M von Meyenfeldt (EM)

Department of Surgical Oncology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

W Edward Visser (W)

Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.

Charlotte van Noord (C)

Department of Internal Medicine, Maasstad Hospital Rotterdam, Rotterdam, The Netherlands.

Hans F Zengerink (HF)

Department of Surgery, Franciscus Gasthuis & Vlietland Rotterdam, Rotterdam, The Netherlands.

Marc R J Ten Broek (MRJ)

Department of Nuclear Medicine, Reinier de Graaf Hospital Delft, Delft, The Netherlands.

Cornelis Verhoef (C)

Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Robin P Peeters (RP)

Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.

Tessa M van Ginhoven (TM)

Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Classifications MeSH